(Q40355484)

19 September 2017

title

2C4, a monoclonal antibody against HER2, disrupts the HER kinase signaling pathway and inhibits ovarian carcinoma cell growth (English)

1 reference

19 September 2017

1 reference

1 reference

1 reference

1 reference

8

David B Agus

1 reference

19 September 2017

Noriyuki Takai

1

1 reference

19 September 2017

Anjali Jain

2

1 reference

19 September 2017

Norihiko Kawamata

3

1 reference

19 September 2017

Laura M Popoviciu

4

1 reference

19 September 2017

Jonathan W Said

5

1 reference

19 September 2017

Sadie Whittaker

6

1 reference

19 September 2017

Isao Miyakawa

7

1 reference

19 September 2017

H Phillip Koeffler

9

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

19 September 2017

1 reference

19 September 2017

volume

104

1 reference

19 September 2017

issue

12

1 reference

19 September 2017

page(s)

2701-2708

1 reference

Untangling the ErbB signalling network

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21533

The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21533

A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21533

Regulation of signal transduction and signal diversity by receptor oligomerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21533

Specificity within the EGF family/ErbB receptor family signaling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21533

Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21533

Applications of eTag trade mark assay platform to systems biology approaches in molecular oncology and toxicology studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21533

The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21533

Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21533

Smart drugs: tyrosine kinase inhibitors in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21533

Inhibitors of tyrosine kinases in the treatment of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21533

Epidermal growth factor-related peptides and their receptors in human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21533

7 January 2021

Signal transduction through MAP kinase cascades

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21533

7 January 2021

Vitamin D2 analog 19-nor-1,25-dihydroxyvitamin D2: antitumor activity against leukemia, myeloma, and colon cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21533

7 January 2021

Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21533

7 January 2021

Identifiers

DOI

10.1002/CNCR.21533

1 reference

19 September 2017

1 reference